RxDoctor Payments Data

Nathan Bell, APRN

Family · Las Vegas, NVNPI 1396396529

Payments from drug & device makers

$1,562in general payments, 2019–2025

Across 58 payments — averaging $26.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • Idorsia Pharmaceuticals US Inc$190
  • IBSA Pharma Inc.$143
  • Forte Bio-pharma LLC$131
  • Biodelivery Sciences International, Inc.$24
  • Biohaven Pharmaceutical Holding Company Ltd.$15
  • plus $27 from 2 others

What the payments were for

  • Food & beverage$1,562100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,562 in reported general payments places this provider in the 75th percentile of 1,501 family providers in Nevada.

See all family providers in Nevada

Medicare billing

Part B allowed, 2024
$42,632
Medicare patients
49
Services billed
418

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate16$26,913
MovantikNaloxegol Oxalate47$21,837
OxycontinOxycodone Hcl25$17,375
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen290$9,147
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen179$7,777
Diclofenac Sodium33$4,153
Tizanidine Hcl46$3,304
Oxycodone Hcl179$2,910
Morphine Sulfate ErMorphine Sulfate96$2,104
Gabapentin97$1,060
Pregabalin49$956
Lidocaine20$939
Cyclobenzaprine Hcl75$705
Methocarbamol52$564
Tramadol Hcl ErTramadol Hcl13$513

Paid to pharmacies, not to this prescriber.

Other family in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →